Acurx Pharmaceuticals (ACXP) Misses Q2 EPS by 5c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q2 EPS of ($0.28), $0.05 worse than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Ridgepost Capital acquires Stellus Capital Management for $4B AUM
• Robinhood prices $2B convertible notes offering due 2029